" class="no-js "lang="en-US"> Meriam Kabbaj - Medtech Alert
Wednesday, September 17, 2025
Meriam Kabbaj

Meriam Kabbaj

About Meriam Kabbaj

• Passionate and entrepreneurial mind, who co-founded a biotech company and secured seed money for the development of an orphan product.

• Creative and critical thinker, collaborates with consultants and key opinion leaders to optimize early development strategies within the boundaries of regulatory requirements and seek for new indication opportunities for the product under development.

• Focused and reliable project manager with strong team spirit who enables timely internal decision-making and manages external communication with investigators, Contract Research Organizations (CROs) and regulatory agencies.

• Dedicated and inspirational leader who manages staff responsible for study design, protocol writing, data analysis, and reporting of preclinical / early stage clinical studies.

• Clinical pharmacology expert, assessing pharmacokinetics, absorption, distribution, metabolism, and excretion (ADME), and drug-drug interactions (DDIs) across all product development phases.

Specialties: Start-up, Seed founding, Early Phase Drug Development, Clinical Pharmacology, Pharmacokinetics, Pharmacodynamics, ADME.

Related Story

GENFIT Acquires Swiss Biotech Versantis for Over CHF105 Million

September 20 2022

GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of […]